RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)
May 2011 - 5 pages - $500
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Follicular Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 213 pages - $500
Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 672 pages - $500
Mantle Cell Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 268 pages - $500
Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015
Jan 2011 - 124 pages - $1,740
Diffuse Large B-Cell Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 351 pages - $500
Cutaneous T-Cell Lymphoma - Pipeline Review, Q4 2010
Dec 2010 - 47 pages - $500
Lymphoma Therapy Area Pipeline Report
Nov 2010 - 233 pages - $1,495
Scotland and Newcastle Lymphoma Group – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 28 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Therapeutic target
Oncology del
Lymphoma del
Development phase
Preregistration del

Browse By

Industry sector
Intravesical
Nasal
Nasal topical
Ophthalmic
Oral liquid
Oral solid
Otic
Parenteral
Pulmonary
Rectal
Systemic
Topical
Vaginal
Therapeutic target
Hodgkin's lymphoma
Lymphoma, AIDS-related
Neoplastic disease
Non-Hodgkins lymphoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us